Precision Medicine and/or Biomarker Based Therapy in T2DM: Ready for Prime Time?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Precision Medicine and/or Biomarker Based Therapy in T2DM: Ready for Prime Time?
Authors
Keywords
-
Journal
SEMINARS IN NEPHROLOGY
Volume 43, Issue 3, Pages 151430
Publisher
Elsevier BV
Online
2023-10-19
DOI
10.1016/j.semnephrol.2023.151430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes
- (2022) John J. Nolan et al. DIABETES CARE
- Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
- (2022) Rodica Pop-Busui et al. DIABETES CARE
- Molecular Mechanisms and Therapeutic Targets for Diabetic Kidney Disease
- (2022) Katherine R. Tuttle et al. KIDNEY INTERNATIONAL
- Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort
- (2022) Ninna Hahn Tougaard et al. DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2022) Melanie J. Davies et al. DIABETES CARE
- Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
- (2022) Ian H. de Boer et al. DIABETES CARE
- Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial
- (2022) Viktor Rotbain Curovic et al. DIABETES CARE
- Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture
- (2021) Peter Rossing et al. DIABETES
- Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
- (2021) Emilie H Zobel et al. BMJ Open Diabetes Research & Care
- Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
- (2021) Mengyuan Ge et al. Journal of Personalized Medicine
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
- (2021) Ahmed M. Shaman et al. CIRCULATION
- Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
- (2020) Nete Tofte et al. Lancet Diabetes & Endocrinology
- Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes
- (2020) Mikael Croyal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
- (2020) Alessandro Doria et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes
- (2020) Christine P. Limonte et al. AMERICAN JOURNAL OF NEPHROLOGY
- Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria
- (2020) Signe A. Winther et al. DIABETOLOGIA
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial
- (2020) Austin G. Stack et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
- (2019) Radica Z. Alicic et al. DIABETES
- Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes
- (2019) Signe A. Winther et al. DIABETES CARE
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
- (2019) Monika A. Niewczas et al. NATURE MEDICINE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria
- (2019) Sadayoshi Ito et al. Clinical Journal of the American Society of Nephrology
- Effects of Selonsertib in Patients with Diabetic Kidney Disease
- (2019) Glenn M. Chertow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
- (2019) Nete Tofte et al. Scientific Reports
- Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria
- (2018) Daniel G.K. Rasmussen et al. DIABETES CARE
- Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
- (2018) Kathryn C. B. Tan et al. DIABETOLOGIA
- Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic ActivityNovelty and Significance
- (2018) Jana Grune et al. HYPERTENSION
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- Cardiorenal Syndrome Revisited
- (2018) Faiez Zannad et al. CIRCULATION
- Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy
- (2017) Julie Galsgaard et al. KIDNEY INTERNATIONAL
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and Progression of CKD: The CRIC Study
- (2016) R. L. Amdur et al. Clinical Journal of the American Society of Nephrology
- JAK inhibition in the treatment of diabetic kidney disease
- (2016) Frank C. Brosius et al. DIABETOLOGIA
- Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics
- (2016) Anna Solini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
- (2016) M. Garsen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
- (2016) Gemma Currie et al. BMC Nephrology
- Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction
- (2016) Kasper Rossing et al. PLoS One
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus
- (2014) M. J. Pena et al. DIABETIC MEDICINE
- Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
- (2014) Peter Kolkhof et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
- (2014) Monika A. Niewczas et al. KIDNEY INTERNATIONAL
- Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
- (2013) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Gut Microbiome, Kidney Disease, and Targeted Interventions
- (2013) A. Ramezani et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
- (2011) Akshay S. Desai et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals
- (2010) Christian Delles et al. JOURNAL OF HYPERTENSION
- Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
- (2010) David M. Good et al. MOLECULAR & CELLULAR PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started